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DESIGN AND DEVELOPMENT OF A QUARTZ 
CRYSTAL MICROBALANCE 























Background: Quartz crystal microbalances (QCMs) consist of a quartz crystal of known 
resonance frequency, the change in which can be measured and analyzed to determine the 
mass that is loaded onto the device.  
 
A schematic diagram of a QCM, showing the layout of the inlet and outlet tubes, the crystal, 
and the gold electrode. Figure reproduced from ANT Technology Co., Ltd 
 
 
A typical graph of frequency vs. time produced by a QCM in response to binding of analytes. 
Figure reproduced from Chemosensors1 
 
The technology has existed for several decades, but uses are still being discovered and explored 
presently. In 1959, Dr. Günter Sauerbrey developed what is now known as the Sauerbrey 
equation. This achieved the mathematical description of the change in resonant frequency of a 








Where ∆𝑓 is the observed change in frequency, 𝑓0 is the resonant frequency of the crystal, ∆𝑚 
is the mass deposited on the crystal, 𝐴 is the active crystal area, 𝜌𝑞  is the density of the quartz, 
and 𝜇𝑞  is the shear modulus of the quartz. 
 
William H King, Jr. first wrote about the use of a QCM as a gas adsorption sensor in 
19642. Since then, QCMs have also been applied to analytes in vacuum3 and in liquid media4 to 
serve as tools for microgravimetry and viscosity testing. Since the sensitivity of the 
measurements made with a QCM is dependent only on the measurement of frequency, which 
is done easily with high accuracy and precision, QCMs were first used simply to measure 
extremely small masses. Applications were soon found in the field of biochemistry, however.  
 
Chemists discovered that a QCM could be coated with certain materials that would 
make biomolecules of interest attach to the surface. If the analytes in question were in 
solution, the solution could be pumped over the crystal, depositing the biomolecules onto the 
surface and thus altering the resonant frequency. One early experiment used a crystal coated in 
polystyrene to detect the adsorption of insulin and related antibodies, which readily bound to 
the surface, while also showing that other molecules went undetected on the sensor5. The most 
common modification of QCMs for immunosensing is the addition of gold electrodes to the 
surface of the crystal. The gold electrode allows for the immobilization of several important 
groups in the field of biochemistry. A 2003 experiment formed a monolayer on the gold surface 
with 3-mercaptopropionic acid, resulting in a layer of carboxylic acid groups to interact with the 
analytes6. Schistosoma-japonicum molecular antigen was then attached to the carboxylic acid 
groups, and rabbit blood serum could be passed over the quartz crystal to determine if the 
blood was infected with the schistosomiasis parasite. The QCM is sensitive enough to detect 
the binding of molecules to the antigen, and thus a low-cost, small, portable infection detector 
had been created.  
 
As stated before, the gold electrodes present on the surface of most QCMs allow for the 
immobilization of several groups of analytical interest. Thiol groups readily adsorb onto gold 
surfaces to form monolayers, allowing a straightforward mechanism for the immobilization of a 
wide range of synthetic and biological molecules. This strategy enables the immobilization of 
cysteine-containing proteins onto the surface of a QCM crystal. Protein G can be easily 
thiolated through the use of reagents such as 2-iminothiolane7, leading to the easy formation of 
a Protein G monolayer. Antibodies will bind to protein G through their non-antigenic region, 
allowing for antigen in an analyte solution to bind the antibody and be detected by QCM. 
Protein A, another antibody-binding protein, can be immobilized onto gold surfaces, even 
without derivatization with thiols. Researchers have shown Protein A will form a monolayer on 
a gold electrode surface and allow for the immobilization of antibodies with more success than 
other methods involving multiple molecules8. The ease of immobilization for Protein A and 
Protein G makes the QCM a very valuable and intriguing tool for the analysis of biomolecules, 
since those proteins can bind a wide of antibodies and other compounds of interest.  
 
The analytes at the center of this semester’s work are exosomes. Exosomes are 
extracellular vesicles secreted by most types of human cells, but their secretion is not as well-
studied or understood as other important biomolecules of the body. Their exterior consists of a 
lipid bilayer. The lipid bilayer encloses fluid that is protected from the outside environment. 
Often, the fluid will contain important regulatory biomolecules, such as enzymes or RNA. 
Intracellular secretory vesicles fuse with the cell membrane in order to release their contents 
into extracellular space. Multivesicular bodies are secretory vesicles that contain additional 
vesicles; these secreted vesicles have the potential to fuse with another cell membrane, 
releasing their contents into a new cell. The vesicles secreted via multivesicular bodies are 
exosomes. Often, exosomes will travel to a cell far away from its origin to release what it 
carries. Because of this capability, exosomes are thought to be a potential major player in cell 
signaling. Even if exosomes are only a simple delivery mechanism between cells, the potential 
clinical applications for exosomes are very intriguing. It is certainly feasible that exosomes could 
be developed to serve as biomarkers for disease or vessels for delivery of medication in the 
future. 
 
Unfortunately, as stated before, exosomes and their secretion dynamics are not well 
understood at this time. This is due to their miniscule size (typ. 50 – 100 nm diameter), which 
leads to great difficulty for their isolation and detection. The goal of the semester’s research is 
to begin development of a QCM sensor specific for exosomes. The QCM’s limit of detection, 
combined with the Sauerbrey equation, means changes in mass of at least 1.56 ng are reliably 
detectable. Since the mass of a typical exosome is 6.02 • 10-7 ng, and the typical concentration 
of exosomes in biofluids is 1 • 1011 exosomes/mL, a volume of 25.9 nL biofluids should be 
enough for reliable detection of exosomes. A major challenge is the selection and development 
of an appropriate system of molecules for immobilization on the gold electrode to attach 
exosomes, as well as a method of introducing the exosomes to the QCM to selectively 
immobilize exosomes for detection. If this goal can be met, it would enable new discovery in 
the fields of bioanalysis and medicine. Even better, if this can be done by a QCM alone, the 
method will be very cost-effective and relatively simple for a solution to a problem of this 
magnitude and importance. 
 
Materials and Methods: Glycerol, insulin, bovine serum albumin, dithiothreitol, NaCl, KCl, 
Na2HPO4, KH2PO4, C2H3NaO2, and CH3COOH were purchased from Sigma-Aldrich (St. Louis, MO). 
Protein A was purchased from ProSpec (East Brunswick, NJ). Phosphate-buffered saline (PBS) 




Unless otherwise noted, all solutions were made with PBS as the solvent.  
 
Verification of Equilibration Time and Standard Deviations 
The QCM arrived with a data sheet detailing the equilibration time and standard 
deviation of the results when analyzing static liquid and air in an open or closed environment. 
These numbers were verified in the laboratory. First, the QCM was left open to the air and 
allowed to equilibrate. Next, the QCM was put in the “closed” position by securing the lid on 
top, and once again allowed to equilibrate. Finally, milliQ water was placed onto the QCM 
crystal, and the device was placed in the closed position and allowed to equilibrate once more. 
The equilibration values and standard deviations were recorded. 
 
Glycerol Viscosity Testing 
 Five glycerol standards were prepared ranging from 0% - 20% (w/w), as detailed in the 
table below: 
 
% glycerol by mass Volume glycerol (mL) Volume milliQ water (mL) 
0 0.000 5.000 
5 0.200 4.800 
10 0.405 4.595 
15 0.614 4.386 
20 0.828 4.172 
 
 The volumes were pipetted into vials for storage until they were analyzed with the 
QCM. Each standard was allowed to reach equilibrium, and then the next standard was pumped 
onto the QCM in ascending order by mass percent. 
 
Thiol Immobilization and Insulin Testing 
 First, stock solutions of insulin and DTT were prepared. The insulin solution was 
prepared at a concentration of 10 mg/mL, which corresponds to 0.174 mM. The DTT stock 
solution was prepared at half the concentration of insulin, or 0.087 mM. These stock solutions 
were kept in storage at -20 C. At least 24 hours before each trial was run in this experiment, 
reaction mixtures would be prepared by mixing 1 mL insulin stock solution with 1 mL PBS, and 
also mixing 1 mL insulin stock solution with 1 mL DTT stock solution. In the first version of this 
experiment, the QCM was loaded with PBS and allowed to equilibrate. Next, the insulin/PBS 
solution was loaded and allowed to equilibrate. The QCM was then flushed with PBS and finally 
loaded with the insulin/DTT solution and allowed to equilibrate. In the second version of this 
experiment, the QCM was loaded with PBS and allowed to equilibrate. Next, the insulin/DTT 
solution was loaded and allowed to equilibrate. Finally, the QCM was flushed with PBS and 
allowed to come to equilibrium.  
 
Thiol Immobilization and BSA Testing 
 First, a stock solution of BSA was prepared at a concentration of 0.174 mM. The second 
version of the procedure detailed above for thiol immobilization and insulin testing was 
repeated while substituting BSA for insulin.  
 
Protein A Testing 
 First, a stock solution of Protein A was prepared at a concentration of 2.5 mg/mL. Next, 
a  0.1 M sodium acetate buffer was prepared and HCl was added dropwise to bring the pH to 
4.69. The QCM was loaded with PBS, and the crystal’s equilibration value was determined. 
Then, the crystal was removed, and 10 L Protein A was pipetted onto the electrode surface, 
followed quickly by 10 L sodium acetate buffer. The crystal was allowed to incubate at room 
temperature for two hours with the solutions, at which time it was analyzed in PBS with the 
QCM and compared to the prior resonant frequency in PBS.  
 
Results/Discussion: 
Verification of Equilibration Time and Standard Deviations 
As described above, the initial testing of the crystal simply assured that it was working 
properly and to the standards desired for experimentation moving forward. Testing confirmed 
that when the crystal was running in air (closed or open) or static fluid, equilibrium was reached 
in under 30 minutes, and the standard deviation for the measurement was below 1 Hz for each 
scenario, corresponding to a relative standard deviation of less than 0.00001%. These results 
allow for the determination of a limit of detection (LOD) for the QCM, as well as a calculation of 
the amount of biofluids needed for the detection of exosomes. For the purposes of this work, 
LOD is defined as the minimum amount of analyte required to achieve a signal/noise ratio of 3. 
The standard deviation from static fluid determined above serves as the value for noise, 
meaning the minimum signal needed is a shift of 1.25 Hz. From the Sauerbrey equation, this 
corresponds to a mass of 1.56 ng. Exosomes are spherical macromolecules with a diameter of 
100 nm and a density of 1.15 g/mL. This means that the mass of a single exosome is 6.02 • 10-7 
ng. Thus, a sample needs at least 2.59 • 106 exosomes for reliable detection. The concentration 
of exosomes in biofluids is known to be around 1 • 1011 exosomes/mL. Using these numbers, it 
can be determined that a 25.9 nL sample of biofluid is the minimum requirement for the 
reliable detection of exosomes. 
 
Glycerol Viscosity Testing 
The Sauerbrey equation described above can be modified to correlate change in 
frequency with the viscosity of the material loaded onto the crystal. The aim of this set of 
experiments was to verify that the resonant frequency of the crystal shifts in response to 
viscosity changes as well as changes in mass. The initial mixtures of glycerol were found to be 
too viscous once 20% (w/w) glycerol was exceeded, as after this point the crystal immediately 
jumped to a resonant frequency reading of 16 MHz, which is the default when the crystal is 
overloaded. This was a valuable lesson to learn early on in the experimental process, as this 
problem was encountered frequently throughout the rest of the semester for various reasons. 
To fix the problem in this situation, a new set of standards were created with 20% (w/w) 
glycerol as the most dense mixture.  
 
 
Figure 1: A plot of change in frequency (Hz) vs. time (s) for glycerol viscosity testing. The steady 
rise between 25 min - 80 min is the equilibration of 5% glycerol. The section from 85 min - 110 
min is the equilibration of 10% glycerol. The section from 110 min – 145 min is 15% glycerol. 
The section from 150 min – 165 min is 20% glycerol. 
 
In the figure above, we see the results of the glycerol viscosity testing. There are several 
points of interest that should be noted. First, the long, gradually flattening increase from time 
~25 min – 80 min  is the equilibration time. This is an example of very poor equilibration time. 
In fact, due to time constraints on this experiment, the first two samples had to be removed 
before they had a chance to fully equilibrate. In any case, the four relatively flat sections 
between the large spikes correspond to the four different standards that were analyzed (from 
left to right: 5% glycerol, 10% glycerol, 15% glycerol, and 20% glycerol). Theoretically, the 
equilibrium values should be highest with the leftmost sample and decrease incrementally as 
the graph continues to the right. It is unclear where the first sample would have equilibrated, 
but it is clear to see that the last three samples did follow the decreasing pattern that was 
expected, even if only two of them reached equilibrium. This experiment was replicated several 
times, but good performance and results were never achieved. This particular endeavor was 
eventually discontinued, as the ultimate goal of this work deals with change in mass, rather 











Thiol Immobilization and Insulin Testing 
 
Figure 2: A plot of change in frequency (Hz) vs. time (min) for the thiol immobilization and 
insulin testing. The first section, from 0 min – 45 min, is the equilibration for pure PBS. The 
second section, from 45 min – 60 min, is the equilibration for the insulin/PBS mixture. The third 
section, from 60 min – 400 min, is the equilibration for the insulin/DTT mixture. 
 
As stated above, thiols easily bind to gold surfaces and can form the basis of many 
immunoassay experiments. To test this process with the QCM in the laboratory, a series of tests 
were run involving Phosphate-buffered saline (PBS), insulin, and dithiothreitol (DTT). Insulin 
contains disulfide bonds, which are readily reduced by DTT to form thiol groups. As can be seen 
above, there are three phases to this specific experiment, again from left to right. The first is 
running PBS on the crystal and achieving equilibrium (due to scale it does not seem as though 
PBS equilibrated, although it did). Next, a mixture of insulin and PBS is analyzed by the QCM. As 
expected, this graph shows a frequency decrease from the first stage to the second. While, 
theoretically, no insulin is attaching to the crystal’s electrode, the viscosity increase is 
significant enough to show a difference. The final stage is an insulin/DTT mixture that has been 
allowed to incubate overnight. It is with this stage that it is expected to observe insulin 
chemically attaching to the electrode after the breaking of its disulfide bonds by DTT, exposing 
free thiols for gold immobilization. This happens at a slow enough pace that it is actually 







Figure 3: A plot of change in frequency (Hz) vs. time (min) for the thiol immobilization and 
insulin testing. The first section, from 0 min – 40 min, is the equilibration for PBS. The second 
section, from 40 min – 345 min, is the equilibration for the insulin/DTT mixture. The third 
section, from 350 min – 400 min, is the equilibration for the second run of PBS. 
 
Shown above is the second part of the experiments involving thiol immobilization and 
insulin. After the first part of the experiment, detailed above, there was some slight concern 
that the decrease in resonant frequency observed when the insulin/DTT mixture was analyzed 
was a result of a change in viscosity, rather than a change in mass from insulin binding to the 
gold electrode. To rule out this possibility, the experiment represented above was performed. 
Again, from left to right, the first section is only PBS being analyzed by the device, just as the 
first experiment started out. The difference in this experiment is found in the second section, 
which is the insulin/DTT mixture instead of insulin/PBS. In this section once more the gradual 
decline in resonant frequency is observed as would be expected from insulin binding to the 
electrode. Finally, in the third section is only PBS once more. Since the crystal has been flushed 
with PBS but still shows a significant decrease from the original PBS equilibrium, it can be 
determined with confidence that the insulin has been immobilized on the crystal. 
 
Thiol Immobilization and BSA Testing 
 
Figure 4: A plot of change in frequency (Hz) vs. time (min) for the thiol immobilization and BSA 
testing. The first section, from 0 min – 27 min, is the equilibration for PBS. The second section, 
from 28 min – 153 min, is the equilibration for the BSA/DTT mixture. The third section, from 
154 min – 195 min, is the equilibration for the second run of PBS.  
 
Bovine Serum Albumin (BSA) also contains disulfide bonds, and so the previous 
experiment was repeated with BSA in the place of insulin. BSA has a much higher molecular 
weight than insulin, and so the hope for this experiment was to see a much more drastic 
difference in the PBS baseline vs. the BSA frequency shift than was observed during the 
experiment with insulin. As can be seen above, the same rough trends were achieved with BSA 
that were observed with insulin, and there is definite evidence that BSA was immobilized onto 
the crystal. However, the decrease in frequency from the first equilibration of PBS to the 
equilibration of BSA/DTT is not as significant as what was seen in the insulin experiments. Since 
BSA has a much larger mass than insulin, this suggests that the BSA did not bind to the gold 
electrode nearly as readily as the insulin molecules did.  
 
Protein A Testing 
 
Figure 5: A plot of change in frequency vs. time for a crystal in just PBS (orange) and a crystal in 
just PBS after Protein A immobilization (blue). 
 
Protein A was decided to be the agent of choice to help eventually immobilize exosomes 
onto the QCM. First, however, the method of immobilizing Protein A was tested, as set forth by 
Babacan et al. Protein A was deposited on the crystal, followed by sodium acetate buffer, and 
allowed to incubate for two hours at 22 C, then analyzed and compared to the crystal’s 
resonant frequency in PBS, with the hope to see evidence of Protein A immobilization on the 
crystal. 
 
As can be seen from the plot above, there was significant difference in the crystal’s 
resonant frequency before and after the immobilization of Protein A, which is what is expected. 
There is no concern that the difference is due just to viscosity effects here, as both trials plotted 
above simply have the crystal in PBS. There is observed an approximately 260 Hz difference in 
the resonant frequency due to the immobilization of Protein A, which, from the Sauerbrey 
equation, corresponds to about 300 ng of Protein A that has attached to the crystal and is ready 
to bind antibodies or other biomolecules of interest. 
 
 A challenge that has been encountered while working with the QCM is proper storage 
and cleaning of the device and the crystals that go inside of it. These procedures had to be 
developed from existing literature as best as possible and applied while hoping for the best. 
Some problems seem to be had here, especially with the Protein A testing. These tests require 
the crystals to be stored at least one 24-hour period, if not more, and be ready to test again and 
give the same results. This has not yet been achieved to satisfaction, and is something that 
needs to be improved if these QCMs are to truly become effective devices for exosome 
detection. 
 
Conclusion: The goal of this semester’s work is the development of the QCM technology to 
generate a procedure for the detection of exosomes. When looking at the results of the 
experiments as a whole, one can see the progression from basic experiments to more complex 
and important immobilizations that lead to the possibility of detection of exosomes. So far, the 
culmination of the experiments has been the ability to immobilize Protein A on the QCM and 
detect it. At this point going forward, the next step is to explore and experiment with the use of 
various antibodies and similar molecules that have the ability to bind exosomes and similar 
analytes. A standard procedure would need to be developed, and the process would need to be 
able to selectively identify or detect exosomes among other similar molecules that are present 
in an exosome’s normal environment. If this can be achieved, it would be a great breakthrough, 
that will not only contribute to the current knowledge in fields of biochemistry, physiology, etc., 
but will also provide a solution to the struggles of the valuable detection of these molecules at 
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